The activities of
RNase (
RNase-U and
RNase-C) were determined in the serum and leukocytes of 277 patients with 14 cases of various kinds of
eosinophilia (not less than 10(3)/microliters), 28 cases of
chronic myelocytic leukemia (CML), using polyuridylic
acid and
polycytidylic acid as synthetic substrates according to the method of Raddi et al. Serum
RNase-U activity, serum
RNase-C activity and the activity ratio (U/C x 10(-3)) were 55 +/- 14 U, 1,280 +/- 235 U and 44 +/- 11 (mean +/- SD), 196 +/- 137, 1,992 +/- 1,134 U and 97 +/- 38, and 110 +/- 50 U, 1,854 +/- 625 U and 65 +/- 13 for normal subjects,
eosinophilia and CML (untreated), respectively. U/C ratio in
eosinophilia and CML (untreated) showed a highly significant positive correlation (p less than 0.001) with peripheral eosinophil count; the activity of serum
RNase-U per cells in the supernatant of eosinophil homogenate rose significantly (p less than 0.001) compared with that of lymphocytes or granulocytes. Besides, serum and eosinophil
RNase-U had a similar optimal pH. These results suggested that serum
RNase-U in
eosinophilia originated mostly from eosinophils and its rise was correlated strongly with the increase in eosinophils.